Here at FluCamp we work hard to develop treatments against flu. But did you know there are different kinds of flu that circulate within our society? Today we are going
I wanted to share some of the very optimistic news on Omicron that our team of scientists in Open Orphan’s London virology lab are conveying to me. They are now confident
The first‐in‐human (FIH) clinical trial is an important milestone for each development program. For small (bio)pharma companies the FIH trial requires a significant investment, and every sponsor wants to make
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, has announced that hVIVO, a subsidiary of Open
hVIVO, a subsidiary of Dublin-listed Open Orphan has won a $13.4 million (€11.8 million) contract with a leading US biotech company. The contract will see the unnamed company testing its novel
What is RSV in babies? Respiratory Syncytial Virus, commonly referred to as RSV, is a respiratory virus that causes cold-like symptoms in the typical healthy adult, which can last on
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, has announced that hVIVO, a subsidiary of
The efficacy of COVID-19 vaccines in preventing infection, disease, and spread is a topic of increasing importance. TrialSite is following the vaccine mandates and restrictions against the unvaccinated, founded in
Open Orphan plc (LON:ORPH) a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, has noted the announcement
We have all heard of asthma. You may have asthma, you may have a friend or a loved one with asthma, or you may just be aware of it as
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
